![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 33, 31095-31104, August 15, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the aLaboratoire International Associé d'Ingénierie Biomoléculaire, CNRS Unité Mixte de Recherche 6560 Bd Pierre Dramard, 13916 Marseille Cedex 20, France, bInserm EMI 9931, Commissariat à l'Energie Atomique, Institut Fédératif de Recherche 27, Département de Recherche Dynamique Cellulaire, Canaux Ioniques et Signalization, 17 rue des Martyrs, 38054 Grenoble Cedex 09, France, dUniversität Ulm, Albert Einstein-Allee 11, D-89081 Ulm, Germany, the eUniversity of Maryland School of Medicine, Baltimore, Maryland 21201-1509, the fLaboratoire des Venins et Toxines, Institut Pasteur de Tunis, P. O. Box 74, 1002 Belvédàre, Tunis, Tunisia, gArchitecture et Fonction des Macromolécules Biologiques, CNRS Unité Propre de Recherche 9039, 31 Chemin Joseph Aiguier, 13402 Marseille, France, and the hLaboratoire d'Immunologie, Faculté de Médecine Timone, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France
Maurotoxin (MTX) is a 34-residue toxin that has been isolated initially
from the venom of the scorpion Scorpio maurus palmatus. It presents a
large number of pharmacological targets, including small conductance
Ca2+-activated and voltage-gated K+ channels.
Contrary to other toxins of the
-KTx6 family (Pi1, Pi4, Pi7, and
HsTx1), MTX exhibits a unique disulfide bridge organization of the type C1-C5,
C2-C6, C3-C4, and C7-C8 (instead of the conventional C1-C5, C2-C6, C3-C7, and
C4-C8, herein referred to as Pi1-like) that does not prevent its folding along
the classic
/
scaffold of scorpion toxins. Here, we developed an
innovative strategy of chemical peptide synthesis to produce an MTX variant
(MTXPi1) with a conventional pattern of disulfide bridging without
any alteration of the toxin chemical structure. This strategy was used solely
to address the impact of half-cystine pairings on MTX structural properties
and pharmacology. The data indicate that MTXPi1 displays some
marked changes in affinities toward the target K+ channels.
Computed docking analyses using molecular models of both MTXPi1 and
the various voltage-gated K+ channel subtypes (Shaker B,
Kv1.2, and Kv1.3) were found to correlate with
MTXPi1 pharmacology. A functional map detailing the interaction
between MTXPi1 and Shaker B channel was generated in line
with docking experiments.
Received for publication, April 23, 2003 , and in revised form, May 26, 2003.
* This work was supported by CNRS, INSERM, the Commissariat à l'Energie Atomique, and Cellpep S.A. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
c A fellowship recipient from the French Ministry of Research and Technology.
i To whom correspondence should be addressed. Tel.: 33-4-91-69-88-52; Fax: 33-4-91-65-75-95; E-mail: sabatier.jm{at}jean-roche.univ-mrs.fr.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
I. Regaya, C. Beeton, G. Ferrat, N. Andreotti, H. Darbon, M. De Waard, and J.-M. Sabatier Evidence for Domain-specific Recognition of SK and Kv Channels by MTX and HsTx1 Scorpion Toxins J. Biol. Chem., December 31, 2004; 279(53): 55690 - 55696. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |